BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17719812)

  • 1. Perioperative desmopressin prolongs survival in surgically treated bitches with mammary gland tumours: a pilot study.
    Hermo GA; Torres P; Ripoll GV; Scursoni AM; Gomez DE; Alonso DF; Gobello C
    Vet J; 2008 Oct; 178(1):103-8. PubMed ID: 17719812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of adjuvant perioperative desmopressin in locally advanced canine mammary carcinoma and its relation to histologic grade.
    Hermo GA; Turic E; Angelico D; Scursoni AM; Gomez DE; Gobello C; Alonso DF
    J Am Anim Hosp Assoc; 2011; 47(1):21-7. PubMed ID: 21164169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmopressin inhibits lung and lymph node metastasis in a mouse mammary carcinoma model of surgical manipulation.
    Giron S; Tejera AM; Ripoll GV; Gomez DE; Alonso DF
    J Surg Oncol; 2002 Sep; 81(1):38-44. PubMed ID: 12210026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmopressin reduces melanoma lung metastasis in transgenic mice overexpressing tissue inhibitor of metalloproteinases-1.
    Ripoll GV; Farina HG; Yoshiji H; Gomez DE; Alonso DF
    In Vivo; 2006; 20(6B):881-5. PubMed ID: 17203783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the synthetic vasopressin analog desmopressin in a mouse model of colon cancer.
    Ripoll GV; Garona J; Hermo GA; Gomez DE; Alonso DF
    Anticancer Res; 2010 Dec; 30(12):5049-54. PubMed ID: 21187489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmopressin and other synthetic vasopressin analogues in cancer treatment.
    Gomez DE; Ripoll GV; Girón S; Alonso DF
    Bull Cancer; 2006 Feb; 93(2):E7-12. PubMed ID: 16517412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between the action of arginine vasopressin and responsiveness to oral desmopressin in older men: a pilot study.
    Johnson TM; Burridge A; Issa MM; Miller M; Tang T; Ouslander JG
    J Am Geriatr Soc; 2007 Apr; 55(4):562-9. PubMed ID: 17397435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
    Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
    J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective randomized trial of desmopressin in canine mammary carcinoma.
    Sorenmo K; Durham AC; Evans B; Scavello H; Stefanovski D
    Vet Comp Oncol; 2020 Dec; 18(4):796-803. PubMed ID: 32441479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of perioperative desmopressin in cats with mammary carcinoma treated with bilateral mastectomy.
    Wood CJ; Chu ML; Selmic LE; Mayhew PD; Holt DE; Martano M; Séguin B; Singh A; Boston SE; Lux C; Liptak JM
    Vet Comp Oncol; 2021 Dec; 19(4):724-734. PubMed ID: 32619339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and significance of PTEN in canine mammary gland tumours.
    Qiu C; Lin D; Wang J; Wang L
    Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of effects of levamisole and surgery on canine mammary cancer.
    MacEwen EG; Harvey HJ; Patnaik AK; Mooney S; Hayes A; Kurzman I; Hardy WD
    J Biol Response Mod; 1985 Aug; 4(4):418-26. PubMed ID: 4031952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effects of desmopressin in combination with chemotherapeutic agents in a mouse model of breast cancer.
    Ripoll GV; Giron S; Krzymuski MJ; Hermo GA; Gomez DE; Alonso DF
    Anticancer Res; 2008; 28(5A):2607-11. PubMed ID: 19035285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canine mammary tumours, an overview.
    Sleeckx N; de Rooster H; Veldhuis Kroeze EJ; Van Ginneken C; Van Brantegem L
    Reprod Domest Anim; 2011 Dec; 46(6):1112-31. PubMed ID: 21645126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on histogenesis of mixed tumours of the mammary gland in bitches.
    Smiech A; Lopuszyński W; Nozdryn-Płotnicki Z
    Pol J Vet Sci; 2002; 5(4):217-22. PubMed ID: 12512553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of desmopressin in open-heart surgery.
    Cattaneo M
    Haemophilia; 2008 Jan; 14 Suppl 1():40-7. PubMed ID: 18173693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of VEGF-C expression in canine mammary tumours.
    Qiu C; Lin DD; Wang HH; Qiao CH; Wang J; Zhang T
    Aust Vet J; 2008 Jul; 86(7):279-82. PubMed ID: 18616481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of desmopressin in von Willebrand disease: the experience of the first 30 years (1977-2007).
    Federici AB
    Haemophilia; 2008 Jan; 14 Suppl 1():5-14. PubMed ID: 18173689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence.
    Sorenmo KU; Kristiansen VM; Cofone MA; Shofer FS; Breen AM; Langeland M; Mongil CM; Grondahl AM; Teige J; Goldschmidt MH
    Vet Comp Oncol; 2009 Sep; 7(3):162-72. PubMed ID: 19691645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insight into the effect of the vasopressin analog desmopressin on lung colonization by mammary carcinoma cells in BALB/c mice.
    Garona J; Pifano M; Scursoni AM; Gomez DE; Alonso DF; Ripoll GV
    Anticancer Res; 2014 Sep; 34(9):4761-5. PubMed ID: 25202055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.